Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (641-650 of 664) with videos related to

Pageof 67
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive DatabaseLindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 8, 2024
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapyJoao Gorgulho, Sven H Loosen, Ramsha Masood, et al.
JAMA Network Open|September 21, 2019
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal CancerTomasz Burzykowski, Elisabeth Coart, Everardo D Saad, et al.
Nature|May 13, 2025
Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerJoseph Tintelnot, Yang Xu, Till R Lesker, et al.
JAMA Network Open|March 25, 2024
A Multimodal Lifestyle Psychosocial Survivorship Program in Young Cancer Survivors: The CARE for CAYA Program-A Randomized Clinical Trial Embedded in a Longitudinal Cohort StudyJulia von Grundherr, Simon Elmers, Barbara Koch, et al.
Therapeutic Advances in Medical Oncology|July 15, 2021
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysisJun Yin, Shaheenah Dawood, Romain Cohen, et al.
Nature|February 22, 2023
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerJoseph Tintelnot, Yang Xu, Till R Lesker, et al.
JNCI Cancer Spectrum|May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical TrialsNadine J McCleary, William S Harmsen, Ellana Haakenstad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric StudyKlaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Cancers|August 26, 2023
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD DatabaseFang-Shu Ou, Daniel H Ahn, Jesse G Dixon, et al.
Pageof 67

Showing results (641-650 of 664) with videos related to

Sort By:
Pageof 67
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive DatabaseLindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 8, 2024
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapyJoao Gorgulho, Sven H Loosen, Ramsha Masood, et al.
JAMA Network Open|September 21, 2019
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal CancerTomasz Burzykowski, Elisabeth Coart, Everardo D Saad, et al.
Nature|May 13, 2025
Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerJoseph Tintelnot, Yang Xu, Till R Lesker, et al.
JAMA Network Open|March 25, 2024
A Multimodal Lifestyle Psychosocial Survivorship Program in Young Cancer Survivors: The CARE for CAYA Program-A Randomized Clinical Trial Embedded in a Longitudinal Cohort StudyJulia von Grundherr, Simon Elmers, Barbara Koch, et al.
Therapeutic Advances in Medical Oncology|July 15, 2021
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysisJun Yin, Shaheenah Dawood, Romain Cohen, et al.
Nature|February 22, 2023
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerJoseph Tintelnot, Yang Xu, Till R Lesker, et al.
JNCI Cancer Spectrum|May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical TrialsNadine J McCleary, William S Harmsen, Ellana Haakenstad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2019
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric StudyKlaus-Peter Dieckmann, Arlo Radtke, Lajos Geczi, et al.
Cancers|August 26, 2023
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD DatabaseFang-Shu Ou, Daniel H Ahn, Jesse G Dixon, et al.
Pageof 67